ClinicalTrials.gg
CompletedNCT03763955H_F_ D_PD_MIRTUpdated Dec 4, 2018

Effectiveness of MIRT on Hand and Finger Dexterity in PD Patients

An observational study in Parkinson Disease, Dexterity and Rehabilitation, sponsored by Ospedale Generale Di Zona Moriggia-Pelascini. Completed. Per ClinicalTrials.gov, last updated 2018-12-04.

Sponsored by Ospedale Generale Di Zona Moriggia-Pelascini · Observational

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
482
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 23 studies in Parkinson Disease by Ospedale Generale Di Zona Moriggia-Pelascini — none open to participants now, none under way, none of them phase 3. Parkinson Disease · Ospedale Generale Di Zona Moriggia-Pelascini.

Enrollment
2nd of 10
482 · median 80
Started
2015
with 5 others
Observational
10 of 23
none open now
Registered
20th of 23
by date

Among the 23 studies in Parkinson Disease by Ospedale Generale Di Zona Moriggia-Pelascini, this one is the 2nd largest by enrollment of the 10 observational ones that give a count, is one of 6 that started in 2015, is one of 10 observational ones, and was the 20th registered.

Parkinson Disease

4,573 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

None of the 23 studies in Parkinson Disease by Ospedale Generale Di Zona Moriggia-Pelascini is open now. The open studies under Parkinson Disease, anywhere →

Where they have run

Who these studies take

Of the 748 Parkinson Disease studies recruiting now, 311 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 63 take children under 18; 189 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 23 studies in Parkinson Disease by Ospedale Generale Di Zona Moriggia-Pelascini as a file.
02

Study summary

Aims of the study are (1) to evaluate the effectiveness of a specific OT treatment aimed to enhance finger and hand dexterity and (2) its impact on daily living autonomy of PD patients.

Read the detailed description

Reduction in hand functionality and finger dexterity are significant, but often overlooked, symptoms of Parkinson's Disease (PD). They are strictly correlated with loss of patient's autonomy, due to their significant impact on Activities of Daily Living (ADL) and, consequently in patient's Quality of life (QoL). No studies investigated the effectiveness of a specific and functional-based Occupational Therapy (OT) treatment in improving hand functionality and finger dexterity in PD patients.

Aims of tthe study are to evaluate the effectiveness of a specific OT treatment aimed to enhance finger and hand dexterity and its impact on daily living autonomy of PD patients.

Retrospectively, 482 PD patients, hospitalized for a 4-week Multidisciplinary Intensive Rehabilitation Treatment (MIRT) between January 2015 and January 2018 were identified. All patients underwent 1h/day OT treatment. The outcome measure was the O'Connor finger dexterity test; secondary outcome measures were Minnesota dexterity test, UPDRS II and SPDDS scale. These measures were assessed at admission (T0) and discharge (T1).

03

Conditions studied

  • Parkinson Disease
  • Dexterity
  • Rehabilitation

Browse trials for

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Parkinsonian inpatients

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • diagnosis of Parkinson's Disease

Exclusion criteria

Exclusion Criteria:

  • other neurological disease
  • psychosis
  • auditive or visual deficit
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
482 participants (actual)
Patient registry
No

Groups and cohorts

  • PD patients

    PD patients at 1-5 H\&Y stage undergoes 4week Multidisciplinary Intensive Rehabilitation Treatment

    Behavioral: MIRT

Interventions

  • BehavioralMIRT

    4 week MIRT provide: 1. front to front treatment (1 hour/day for 5 days/week) 2. treatment with robotic devices (1 hour/day for 5 days/week) 3. occupational therapy (1 hour/day for 5 days/week)

    Also known as: Multidisciplinary Intensive Rehabilitation Treatment

06

What researchers measure

Primary outcomes

  1. O'Connor Finger Dexterity Test

    peg-placement test aimed to evaluate the ability to manipulate small objects

    Time frame: 4 weeks

Secondary outcomes

  1. Minnesota Manual Dexterity Test

    test aimed to evaluate the reach-to-grasp movements, gros manual dexterity and left vs right manual impairment

    Time frame: 4 weeks

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2015 to primary completion in Aug 2018, 43 months.

Of 378 non-industry observational studies under Parkinson Disease, half reached primary completion within 48 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 133. This study's 43 months is below that.

Counting every sponsor, half of 438 studies reached it within 47 months; a quarter within 22 and three quarters within 114.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 26, 2018
First posted
Dec 4, 2018
StartActual
Jan 1, 2015
Primary completionActual
Aug 1, 2018
CompletionActual
Aug 1, 2018
Last update
Dec 4, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 4, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03763955
Lead sponsor
Ospedale Generale Di Zona Moriggia-Pelascini
Responsible party
Sponsor
First posted
Dec 4, 2018
Start date
Jan 1, 2015
Primary completion
Aug 1, 2018
Completion
Aug 1, 2018
Last update
Dec 4, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion